1 active not recruiting, 1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Andrea DeCensi: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer. Tamoxifen 10 MG, Exemestane 25 MG - Breast Cancer | Phase 2 | Recruiting | Andrea DeCensi | 140 | 2025-10-01 | 2025-11-18 |
| Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up Tamoxifen, placebo - Carcinoma, Intraductal, Noninfiltrating, Recurrence, Local Neoplasm | Phase 3 | Active not recruiting | Andrea DeCensi | 500 | 2008-11-12 | 2023-07-17 |
Breast Neoplasms (2) · Carcinoma, Intraductal, Noninfiltrating (1) · Neoplasm Recurrence, Local (1)
Tamoxifen (2) · exemestane (1)
Italy (2)
PMID 23106852, PMID 30973790, PMID 33608319, PMID 33767162, PMID 36917758